Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.

[1]  H. N. Bleasdale.  B.C.G. Vaccination by jet injection. , 1965, Tubercle.

[2]  R. Scheuplein,et al.  Percutaneous absorption after twenty-five years: or "old wine in new wineskins". , 1976, The Journal of investigative dermatology.

[3]  P. Elias,et al.  Percutaneous transport in relation to stratum corneum structure and lipid composition. , 1981, The Journal of investigative dermatology.

[4]  J. Graybill,et al.  Amphotericin B in liposomes: a novel therapy for histoplasmosis. , 1982, The American review of respiratory disease.

[5]  G. Martin,et al.  Structure and function of basement membrane. , 1982, The Journal of investigative dermatology.

[6]  P. Elias,et al.  Epidermal lipids, barrier function, and desquamation. , 1983, The Journal of investigative dermatology.

[7]  M. Levine,et al.  Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates , 1984, Nature.

[8]  J. Bellanti,et al.  LIVE ATTENUATED BACTERIAL VACCINES: NEW APPROACHES FOR SAFETY AND EFFICACY , 1985, The Lancet.

[9]  C. Rupprecht,et al.  Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Whittle,et al.  Trials of intradermal hepatitis B vaccines in Gambian children. , 1987, Annals of tropical paediatrics.

[11]  A. Kingsman,et al.  Polyvalent recombinant antigens: a new vaccine strategy. , 1988, Vaccine.

[12]  R. Eckert.  Structure, function, and differentiation of the keratinocyte. , 1989, Physiological reviews.

[13]  R. Steinman,et al.  Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells , 1989, The Journal of experimental medicine.

[14]  M. Foldvari,et al.  Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. , 1990, Journal of microencapsulation.

[15]  G. Gregoriadis.  Immunological adjuvants: a role for liposomes. , 1990, Immunology today.

[16]  Y. Kubota,et al.  Cell adhesion molecules and cutaneous inflammation. , 1991, Seminars in dermatology.

[17]  T. Luger,et al.  Therapeutic use of cytokines in dermatology. , 1991, Journal of the American Academy of Dermatology.

[18]  D. Johnson.  Adenovirus vectors as potential vaccines against herpes simplex virus. , 1991, Reviews of infectious diseases.

[19]  M. Selby,et al.  Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Gaur,et al.  Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. , 1992, Science.

[21]  P. Frenchick,et al.  Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles. , 1992, Vaccine.

[22]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[23]  H L Robinson,et al.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Nabel,et al.  Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[26]  P. Felgner,et al.  Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. , 1993, Human gene therapy.

[27]  Rajesh K. Gupta,et al.  Adjuvants--a balance between toxicity and adjuvanticity. , 1993, Vaccine.

[28]  A. Kingsman,et al.  Hybrid Ty virus-like particles. , 1994, International reviews of immunology.

[29]  R. Kumar,et al.  Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. , 1994, The Journal of biological chemistry.

[30]  E. Nabel,et al.  Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma. , 1994, Human gene therapy.

[31]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Hoffman,et al.  The feasibility of targeted selective gene therapy of the hair follicle , 1995, Nature Medicine.

[33]  D. Fuller,et al.  Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. , 1995, Vaccine.

[34]  L. Hennighausen,et al.  Gene transfer into mammalian cells by jet injection. , 1995, Hybridoma.

[35]  E. Fuchs.  Keratins and the skin. , 1995, Annual review of cell and developmental biology.

[36]  S. Mitragotri,et al.  A mechanistic study of ultrasonically-enhanced transdermal drug delivery. , 1995, Journal of pharmaceutical sciences.

[37]  R. Akhurst,et al.  Liposome-medicated gene transfer and expression via the skin. , 1995, Human molecular genetics.

[38]  D. Porteous,et al.  Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. , 1995, Gene therapy.

[39]  K. Oldenburg,et al.  Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. , 1995, Journal of pharmaceutical sciences.

[40]  A. Bangham.  Surrogate cells or Trojan horses. The discovery of liposomes. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[41]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[42]  D. Hoekstra,et al.  Parameters influencing the introduction of plasmid DNA into cells by the use of synthetic amphiphiles as a carrier system. , 1995, Biochimica et biophysica acta.

[43]  J. Baker,et al.  Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. , 1996, Nucleic acids research.

[44]  Simon C Watkins,et al.  DNA–based immunization by in vivo transfection of dendritic cells , 1996, Nature Medicine.

[45]  S. Pepper,et al.  Immunisation of common marmosets with vaccinia virus expressing Epstein‐Barr virus (EBV) gp340 and challenge with EBV , 1996, Journal of medical virology.

[46]  P. Paronen,et al.  Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure. , 1996, Biochimica et biophysica acta.

[47]  R. Guy,et al.  Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. , 1996, Journal of pharmaceutical sciences.

[48]  J. Reimann,et al.  Virus-Like Particles Induce MHC Class I-Restricted T-Cell Responses , 1996 .

[49]  M. Brook,et al.  Novel polymer‐grafted starch microparticles for mucosal delivery of vaccines , 1996, Immunology.

[50]  M. Yokoyama,et al.  DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity. , 1996, FEMS immunology and medical microbiology.

[51]  S. Beaucage,et al.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Smith,et al.  A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. , 1996, Gene therapy.

[53]  E. Paoletti,et al.  Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization , 1996, European journal of immunology.

[54]  M. Aubert,et al.  Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. , 1996, Revue scientifique et technique.

[55]  F. Brown,et al.  Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals. , 1996, Vaccine.

[56]  D. Lowy,et al.  Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. , 1996, Virology.

[57]  R. Hoffman,et al.  Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. , 1996, Biochemical and biophysical research communications.

[58]  G. Gregoriadis,et al.  Liposome‐mediated DNA vaccination , 1997, FEBS letters.

[59]  L. Falo,et al.  Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity. , 1997, The Journal of investigative dermatology.

[60]  W. Koff,et al.  Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. , 1997, AIDS research and human retroviruses.

[61]  L. Babiuk,et al.  Effect of IL-4 and IL-12 liposomal formulations on the induction of immune response to bovine herpesvirus type-1 glycoprotein D. , 1997, Vaccine.

[62]  G. Theves.  [Smallpox: an historical review]. , 1997, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg.

[63]  D. Tang,et al.  Vaccination onto bare skin , 1997, Nature.

[64]  M. Lotze,et al.  Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity in vivo , 1997, European journal of immunology.

[65]  R. Bryan,et al.  Description of the intrafollicular delivery of large molecular weight molecules to follicles of human scalp skin in vitro. , 1997, Journal of pharmaceutical sciences.

[66]  J. Clegg,et al.  Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. , 1997, Vaccine.

[67]  B. Bodey,et al.  Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. , 1997, In vivo.

[68]  R. Langer,et al.  Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres. , 1997, Biomaterials.

[69]  A. Jayakrishnan,et al.  Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study. , 1997, Journal of biomaterials science. Polymer edition.

[70]  J. Miyazaki,et al.  Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. , 1997, Journal of immunology.

[71]  K. Rice,et al.  Peptide-mediated gene delivery: influence of peptide structure on gene expression. , 1997, Bioconjugate chemistry.

[72]  S. May,et al.  DNA-lipid complexes: stability of honeycomb-like and spaghetti-like structures. , 1997, Biophysical journal.

[73]  R. Wattiaux,et al.  Cationic lipids destabilize lysosomal membrane in vitro , 1997, FEBS letters.

[74]  T. Lehner,et al.  Mucosal immunization with DNA-liposome complexes. , 1997, Vaccine.

[75]  T. Yasuda,et al.  Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids. , 1997, Acta medica Okayama.

[76]  C. Moser,et al.  Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice. , 1997, Vaccine.

[77]  N. Weiner,et al.  Perifollicular transgenic expression of human interleukin-1 receptor antagonist protein following topical application of novel liposome-plasmid DNA formulations in vivo. , 1997, Journal of pharmaceutical sciences.

[78]  S. Johnston,et al.  Biological features of genetic immunization. , 1997, Vaccine.

[79]  T. Braciale,et al.  Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2 Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection , 1997, The Journal of experimental medicine.

[80]  B. Rouse,et al.  Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization , 1997, Journal of virology.

[81]  R. Zinkernagel,et al.  Neutralizing antiviral B cell responses. , 1997, Annual review of immunology.

[82]  N. Phillips,et al.  Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. , 1997, Biochimica et biophysica acta.

[83]  C. Leclerc,et al.  Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[84]  A. Rosenberg,et al.  Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. , 1998, Journal of immunology.

[85]  G. Griffiths,et al.  Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. , 1998, Vaccine.

[86]  M. Brook,et al.  Oral administration of polymer-grafted starch microparticles activates gut-associated lymphocytes and primes mice for a subsequent systemic antigen challenge. , 1998, Vaccine.

[87]  W. Hennink,et al.  2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[88]  H. Davis.  DNA-based immunization against hepatitis B: experience with animal models. , 1998, Current topics in microbiology and immunology.

[89]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[90]  S. Levy,et al.  Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. , 1998, Journal of immunology.

[91]  S. Attah-poku,et al.  Palmitoyl derivatives of interferon α: Potential for cutaneous delivery , 1998 .

[92]  R. Webster,et al.  Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. , 1998, Journal of immunology.

[93]  K. Leong,et al.  Controlled gene delivery by DNA-gelatin nanospheres. , 1998, Human gene therapy.

[94]  G. Cevc,et al.  Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. , 1998, Vaccine.

[95]  T Salditt,et al.  An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. , 1998, Science.

[96]  P. Liljeström,et al.  Enhancing immune responses using suicidal DNA vaccines , 1998, Nature Biotechnology.

[97]  C. Bangham,et al.  Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. , 1998, Vaccine.

[98]  C. Rhodes,et al.  Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. , 1998, Drug development and industrial pharmacy.

[99]  A. Coombes,et al.  The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[100]  M. Prausnitz,et al.  Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. , 1998, Trends in biotechnology.

[101]  P. Coursaget,et al.  In vitro gene transfer using human papillomavirus-like particles. , 1998, Nucleic acids research.

[102]  I. Orme,et al.  DNA vaccines against tuberculosis. , 1998, Novartis Foundation symposium.

[103]  S. W. Kim,et al.  Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. , 1998, Bioconjugate chemistry.

[104]  T J Flotte,et al.  Photomechanical transcutaneous delivery of macromolecules. , 1998, The Journal of investigative dermatology.

[105]  R. Gupta,et al.  Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. , 1998, Developments in biological standardization.

[106]  J. Clegg,et al.  Oral delivery of micro-encapsulated DNA vaccines. , 1998, Developments in biological standardization.

[107]  M. C. Popescu,et al.  Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity. , 1998, Journal of immunology.

[108]  G. Matyas,et al.  Skin immunization made possible by cholera toxin , 1998, Nature.

[109]  A. Andrianov,et al.  Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions. , 1998, Biomaterials.

[110]  A. Maruyama,et al.  A new non-viral DNA delivery vector: the terplex system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[111]  H. HogenEsch,et al.  Induction of pulmonary immunity in cattle by oral administration of ovalbumin in alginate microspheres. , 1998, Immunology letters.

[112]  C. Pouton,et al.  Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[113]  M. Dertzbaugh.  Genetically engineered vaccines: an overview. , 1998, Plasmid.

[114]  G. Matyas,et al.  Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants , 1999, Infection and Immunity.

[115]  D. Liggitt,et al.  Topical gene delivery to murine skin. , 1999, The Journal of investigative dermatology.

[116]  M. Baca-Estrada,et al.  Dermal and transdermal delivery of protein pharmaceuticals: lipid‐based delivery systems for interferon α , 1999, Biotechnology and applied biochemistry.

[117]  M. Suckow,et al.  Oral vaccination of animals with antigens encapsulated in alginate microspheres. , 1999, Vaccine.

[118]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[119]  P. Khavari,et al.  Immunization via hair follicles by topical application of naked DNA to normal skin , 1999, Nature Biotechnology.

[120]  D. McManus,et al.  DNA vaccines: technology and application as anti-parasite and anti-microbial agents. , 1999, Advances in parasitology.

[121]  Kabanov,et al.  Taking polycation gene delivery systems from in vitro to in vivo. , 1999, Pharmaceutical science & technology today.

[122]  A. Urtti,et al.  Liposome-skin interactions and their effects on the skin permeation of drugs. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[123]  N. Sheikh,et al.  Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice. , 1999, Vaccine.

[124]  M. Baca-Estrada,et al.  Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[125]  J. Cleland.  Single-administration vaccines: controlled-release technology to mimic repeated immunizations. , 1999, Trends in biotechnology.

[126]  M. Suckow,et al.  Biodegradable alginate microspheres as a delivery system for naked DNA. , 1999, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[127]  D. Tang,et al.  DNA-based non-invasive vaccination onto the skin. , 1999, Vaccine.

[128]  K. Leong,et al.  Gene transfer by DNA-gelatin nanospheres. , 1999, Archives of biochemistry and biophysics.

[129]  L. Babiuk,et al.  Development of porcine adenovirus-3 as an expression vector. , 1999, The Journal of general virology.

[130]  R. Whalen,et al.  DNA vaccines : Methods and protocols , 2000 .